Marksans Pharma P/E Ratio

Current P/E Ratio

28.73

High Valuation

High - Growth expectations or overvalued

Marksans Pharma (MARKSANS) P/E ratio is 28.73 (High), EPS (TTM) ₹9.22, current price ₹320.15 on NSE vs historical average P/E of 15.12 (85.7th percentile) — High - Growth expectations or overvalued.

Current Valuation Metrics

P/E Ratio 28.73

Current Price ₹320.15

EPS (TTM) ₹9.22

Exchange NSE

Valuation Signal

Signal Overvalued

Historical Avg 15.12

Historical Range 3.55 - 38.27

Percentile 85.7%

Sector Context

Sector Average 56.94

Sector Median 32.06

Sector Rank #11 of 199

Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹10.91

Mar 2026 ₹3.27

Jun 2026 ₹3.47

MARKSANS P/E Ratio — Valuation Signal & Historical Context

Marksans Pharma P/E 28.73 vs historical average 15.12, range 3.55–38.27 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Marksans Pharma share price chart.

Stock appears overvalued with PE of 28.73, suggesting caution for new investments
Current PE is 90.0% above historical average
Trading at discount to sector average PE of 56.94

Marksans Pharma P/E Ratio Historical Trend

MARKSANS annual price-to-earnings ratio — 7 years, EPS and year-end price. Current P/E 28.73 vs historical average 15.12. Also explore MARKSANS stock price history to track price trends across different timeframes.

MARKSANS Historical P/E Ratio — EPS, Year-End Price & Valuation

Marksans Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year	P/E Ratio	EPS (₹)	Year-end Price (₹)	Exchange	Valuation
2025	38.27	7.96	₹304.65	NSE	High
2024	19.76	8.13	₹160.65	NSE	Moderate
2023	8.21	7.17	₹58.85	NSE	Low
2022	11.82	5.23	₹61.80	NSE	Low
2021	10.6	5.75	₹60.95	NSE	Low
2020	3.55	4.83	₹17.15	NSE	Low
2019	13.62	2.07	₹28.20	NSE	Low

MARKSANS vs Healthcare Peers — P/E Ratio Comparison

Marksans Pharma P/E 28.73 vs Healthcare average 56.94, median 32.06 — range 1.99–747.21.

Sector Average

56.94

Sector Median

32.06

Lowest P/E

1.99

Highest P/E

747.21

Companies

199

Company	Symbol	P/E Ratio	Market Cap (₹ Cr)	Valuation
Sunrest Lifescience	SUNREST	1.99	₹66	Low
Murae Organisor	MURAE	2.86	₹41	Low
Colinz Laboratories	COLINZ	3.27	₹9	Low
Phaarmasia	PHRMASI	3.41	₹59	Low
Sun Pharma Advanced Rese…	SPARC	4.03	₹6,361	Low
Dipna Pharmachem	DPL	4.65	₹12	Low
JFL Life Sciences	JFLLIFE	4.95	₹67	Low
Shelter Pharma	SHELTER	5.71	₹56	Low
GKB Ophthalmics	GKB	5.9	₹33	Low
Kabra Drugs	KABRADG	6.29	₹49	Low